| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2895658 | Atherosclerosis Supplements | 2013 | 6 Pages |
Abstract
Ig apheresis for the treatment of DCM patients is associated with the improvement of quality of life and cardiac function regardless of the presence of anti-β1-AR. We suggest that IgG apheresis is a safe and effective method for DCM patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sergey N. Pokrovsky, Marat V. Ezhov, Maya S. Safarova, Marina A. Saidova, Viktor N. Shitov, Marina I. Afanasieva, Andrew I. Khaustov, Irina Yu. Adamova, Olga I. Afanasieva, Gennady A. Konovalov,